Archive for April, 2022

  • Isofol Medical AB (publ) publishes annual report and corporate governance report for 2021

    GOTHENBURG, Sweden, April 27, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company's annual report…

    by
  • Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer

    GOTHENBURG, Sweden, April 22, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis…

    by
  • Notice to attend the Annual General Meeting held on May 19, 2022 in Isofol Medical AB (publ)

    GOTHENBURG, Sweden, April 12, 2022 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), hereby invites the shareholders of Isofol Medical…

    by
  • Isofol Medical AB’s (publ) Nomination Committee proposes New Chair of the Board

    GOTHENBURG, Sweden, April 8, 2022 – The Nomination Committee of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), proposes that Jan…

    by